Tetraspanins variably affect the virulence of <i>E</i>. <i>histolytica</i>. حسب Han Jiang (195350)

Effect of collision speed on COR. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Box plots of the three-dimensional displacement variations and the COR. حسب Yifei Li (198040)

The basic characteristics of the included studies. حسب Junyin Pan (20700411)

الموضوعات:

Common definitions and criteria for metabolic syndrome. حسب Junyin Pan (20700411)

الموضوعات:

Assessment of study bias in the included research. حسب Junyin Pan (20700411)

الموضوعات:

Results of the effect of dietary anthocyanins on health outcomes, including effect size and heterogeneity analysis. حسب Junyin Pan (20700411)

الموضوعات:

Risk of bias assessment for eligible randomized controlled trials. حسب Junyin Pan (20700411)

الموضوعات:

Summary of studies identified in the literature search, including studies excluded from the analysis and reasons for exclusion. حسب Junyin Pan (20700411)

الموضوعات:

The flow chart of study selection process. حسب Junyin Pan (20700411)

الموضوعات:

Data extracted from included studies for the systematic review and meta-analysis. حسب Junyin Pan (20700411)

الموضوعات:

Specifications and outcomes of clinical trial studies included in the meta-analysis. حسب Junyin Pan (20700411)

الموضوعات:

Comparison of TNF- حسب Mahshid Vafajoo (21144147)

Table 1_The impact of IL-17A inhibitors on scalp and gut microbiota in psoriasis.docx حسب Wenxia Huang (12290795)

"…Moreover, the abundance of Roseburia, Megamonas, and the phylum Bacteroidota increased, although the Firmicutes/Bacteroidota (F/B) ratio showed no significant change. Conclusion: IL-17A inhibitor therapy has the potential to improve the structure and diversity of the scalp microbiome, gradually restoring it toward a healthier state while also enhancing gut microbiota diversity. …"